1. Home
  2. PROF vs SOPH Comparison

PROF vs SOPH Comparison

Compare PROF & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • SOPH
  • Stock Information
  • Founded
  • PROF N/A
  • SOPH 2011
  • Country
  • PROF Canada
  • SOPH Switzerland
  • Employees
  • PROF N/A
  • SOPH N/A
  • Industry
  • PROF Medical/Dental Instruments
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PROF Health Care
  • SOPH Health Care
  • Exchange
  • PROF Nasdaq
  • SOPH Nasdaq
  • Market Cap
  • PROF 140.9M
  • SOPH 206.6M
  • IPO Year
  • PROF N/A
  • SOPH 2021
  • Fundamental
  • Price
  • PROF $4.98
  • SOPH $2.99
  • Analyst Decision
  • PROF Strong Buy
  • SOPH Strong Buy
  • Analyst Count
  • PROF 2
  • SOPH 2
  • Target Price
  • PROF $11.50
  • SOPH $6.50
  • AVG Volume (30 Days)
  • PROF 72.4K
  • SOPH 26.8K
  • Earning Date
  • PROF 05-08-2025
  • SOPH 05-06-2025
  • Dividend Yield
  • PROF N/A
  • SOPH N/A
  • EPS Growth
  • PROF N/A
  • SOPH N/A
  • EPS
  • PROF N/A
  • SOPH N/A
  • Revenue
  • PROF $10,680,000.00
  • SOPH $67,173,000.00
  • Revenue This Year
  • PROF $71.17
  • SOPH $14.86
  • Revenue Next Year
  • PROF $134.25
  • SOPH $22.76
  • P/E Ratio
  • PROF N/A
  • SOPH N/A
  • Revenue Growth
  • PROF 48.35
  • SOPH 4.66
  • 52 Week Low
  • PROF $3.90
  • SOPH $2.58
  • 52 Week High
  • PROF $11.42
  • SOPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • PROF 46.29
  • SOPH 47.34
  • Support Level
  • PROF $4.62
  • SOPH $2.90
  • Resistance Level
  • PROF $5.62
  • SOPH $3.33
  • Average True Range (ATR)
  • PROF 0.39
  • SOPH 0.21
  • MACD
  • PROF 0.09
  • SOPH 0.01
  • Stochastic Oscillator
  • PROF 46.51
  • SOPH 44.46

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

Share on Social Networks: